Category: Markets
Published: 2026-06-28T17:10:29.000Z
Rosen Law Firm is encouraging investors of Zoetis Inc. (NYSE:ZTS) to secure legal counsel before the July 27, 2026, lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that Zoetis made false and misleading statements regarding the performance of its flagship Companion Animal products, including Librela, Simparica Trio, Apoquel, and Cytopoint, resulting in investor damages. Investors who purchased Zoetis securities between January 14, 2025, and May 6, 2026, may be entitled to compensation.
News summary curated and translated by CausifyMarket. Always consult original sources before making any financial decision.